Physician

Pathology

Dr. Neda Kalhor, MD

Doctor Neda Kalhor, MD practices Pathology. Neda Kalhor is also published. He has 49 publications published. The lastest publication: "Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.' Neda Kalhor accepts all Medicare patients.

Publications

Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.
Cystic well-differentiated squamous cell carcinoma of the thymus: a clinicopathological and immunohistochemical study of six cases.
Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations.
De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis.
The Hippo coactivator YAP1 mediates EGFR overexpression and confers chemo-resistance in esophageal cancer.
RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer.
An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung.
Combined thymoma-thymic seminoma. Report of 2 cases of a heretofore unreported association.
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing.
Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases.
Colloid carcinoma of the lung: Current views.
Lung carcinoma: Beyond the WHO classification.
Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer.
Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endp...
EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non-Small Cell Lung Carcinoma.
Validation of a Proliferation-based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma.
Well-differentiated adenocarcinoma-bronchioloalveolar carcinoma-in situ adenocarcinoma: a conundrum.
Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagn...
Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.
Perfecting the fine-needle aspirate cell block.
Early-stage pulmonary adenocarcinoma (T1N0M0): a clinical, radiological, surgical, and pathological correlation of 104 cases. The MD Anderson Cancer Center Experience.
Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non-Small-Cell Lung Cancer after Neoadjuvant C...
g-Protein Coupled Receptor Family C, Group 5, Member A (gprc5a) Expression Is Decreased in the Adjacent Field and Normal Bronchial Epithelia of Patients with Chronic O...
Thymoma: current concepts.
Tissue Platinum Concentration and Tumor Response in Non-Small-Cell Lung Cancer.
Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy.
Ewing sarcoma of the kidney: a rare entity.
Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the world health organization schema.
Clinicopathological and immunohistochemical analysis of spindle-cell carcinoid tumour of the lung.
Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas.
Primary pulmonary chondrosarcomas: a clinicopathologic study of 4 cases.
Spindle cell thymomas: an immunohistochemical study of 30 cases.
Oncocytic neuroendocrine tumors of the lung: histopathologic spectrum and immunohistochemical analysis of 15 cases.
Sox10-positive sustentacular cells in neuroendocrine carcinoma of the lung.
Spindle cell thymomas (WHO Type A) with prominent papillary and pseudopapillary features: a clinicopathologic and immunohistochemical study of 10 cases.
Malignant mesothelioma with prominent adenomatoid features: a clinicopathologic and immunohistochemical study of 10 cases.
Invasive spindle cell thymomas (WHO Type A): a clinicopathologic correlation of 41 cases.
Adenomatoid spindle cell thymomas: a clinicopathological and immunohistochemical study of 20 cases.
Primary angiosarcomas of the anterior mediastinum: a clinicopathologic and immunohistochemical study of 9 cases.
Primary myxoma of the lung.
Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung.
Primary sclerosing neuroendocrine carcinomas of the lung: A clinicopathologic and immunohistochemical study of 10 cases.
So-called sclerosing hemangioma of lung: current concept.
Primary oncocytic adenocarcinomas of the lung: a clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases.
Anaplastic large cell lymphoma: another entity in the differential diagnosis of small round blue cell tumors.
Immunohistochemical studies of trophoblastic tumors.
Diagnostic problems with trophoblastic lesions.
TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material.

Doctors Specialties

Cytopathology
Pathology

Accepted Insurances

American Republic
CHAMPVA
Cigna HMO
Cigna PPO
Great West Healthcare-Cigna PPO
LocalPlus
Open Access Plus
Commercial Insurance Company
Coventry Health Care
First Health (Coventry Health Care) PPO
GEHA
HealthSmart
Humana
Mail Handlers Benefit Plan (MHBP)
Medicare MCR
MultiPlan PPO
PHCS Network PPO
Old Surety Life Insurance CompanyMedicare MCR
Choice Plus POS
Navigate HMO
Navigate POS
Options PPO
United Healthcare

Education

University of Texas MD Anderson Cancer Center
University of Texas Health Science Center
Shahid Beheshti University of Medical Sciences

Hospital

University of Texas M.D. Anderson Cancer Center

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1881869485
Last Name Of The Provider	KALHOR
First Name Of The Provider	NEDA
View All

Similar Doctors

	Dr. Thomas M. Wheeler, MD
	Dr. William E. Luper, MD This Doctor is OpenDoctor Recommended.
	Dr. Illana A. Rubenchik, MD This Doctor is OpenDoctor Recommended.
	Dr. Meredith A. Reyes, MD This Doctor is OpenDoctor Recommended.
	Dr. Yun Gong, MD This Doctor is OpenDoctor Recommended.
	Dr. Richard Hausner, MD This Doctor is OpenDoctor Recommended.
	Dr. Nishi Dave, MD This Doctor is OpenDoctor Recommended.
	Dr. Yang O. Huh, MD This Doctor is OpenDoctor Recommended.
	Dr. Jason E. Moss, MD This Doctor is OpenDoctor Recommended.
	Dr. Jamie J. Buryanek, MD This Doctor is OpenDoctor Recommended.
	Dr. Choladda V. Curry, MD This Doctor is OpenDoctor Recommended.
	Dr. William M. Olson, MD This Doctor is OpenDoctor Recommended.
	Dr. Uma R. Kundu, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael G. Swaby, MD This Doctor is OpenDoctor Recommended.
	Dr. William F. Symmans, MD This Doctor is OpenDoctor Recommended.
	Ming Guo, BM